Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease liver disease
Phenotype C0004153|atherosclerosis
Sentences 11
PubMedID- 24794207 Adiponectin has recently been considered as a possible link between liver dysfunction and atherosclerosis in patients with nonalcoholic fatty liver disease (nafld).
PubMedID- 23185655 Despite several previous studies demonstrated the association between nafld and carotid imt and/or carotid plaque, no general consensus exists on the systematic screening of carotid atherosclerosis in patients with fatty liver disease.
PubMedID- 22359630 Objectives: nonalcoholic fatty liver disease (nafld) is associated with advanced atherosclerosis and a higher risk of cardiovascular disease.
PubMedID- 24069270 Pnpla3 gg genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
PubMedID- 24381427 A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
PubMedID- 23085576 Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
PubMedID- 22748277 Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in asian indians.
PubMedID- 22676459 Background: insulin resistance (ir) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (nafld).
PubMedID- 22814750 Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese.
PubMedID- 25463079 Objective: non-alcoholic fatty liver disease (nafld) is associated with atherosclerosis and reduced vascular compliance.
PubMedID- 23626730 Background: non-alcoholic fatty liver disease (nafld) is associated with cardiovascular atherosclerosis independent of classical risk factors.

Page: 1